Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-41,125
Closed -$1.77M 35
2015
Q1
$1.77M Sell
41,125
-111,070
-73% -$4.81M 0.75% 23
2014
Q4
$6.84M Sell
152,195
-1,775
-1% -$72.2K 2.54% 17
2014
Q3
$5.89M Sell
153,970
-25,100
-14% -$1.02M 2.19% 18
2014
Q2
$7.26M Sell
179,070
-51,435
-22% -$2.12M 2.57% 17
2014
Q1
$9.43M Sell
230,505
-70,550
-23% -$2.69M 3.52% 13
2013
Q4
$11.5M Sell
301,055
-4,975
-2% -$171K 4.23% 7
2013
Q3
$10.2M Sell
306,030
-7,500
-2% -$243K 3.98% 8
2013
Q2
$9.63M Buy
+313,530
New +$10.4M 4.04% 9

Other funds holding ORCL

Cabot-Wellington's ORCL Position: Q2 2015 in Review

Cabot-Wellington sold out of Oracle (ORCL) in Q2 2015, closing a stake of 41,125 shares — an estimated $1.77M sold.

Cabot-Wellington first reported a position in ORCL in Q2 2013 and held it in 8 quarters. The position peaked at $11.5M in Q4 2013. 1,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2015.

  • Cabot-Wellington reported no remaining Oracle position as of Q2 2015 after selling out during the quarter.
  • Cabot-Wellington sold 41,125 Oracle shares in Q2 2015, an estimated $1.77M.
  • Cabot-Wellington first reported a position in Oracle in Q2 2013 and held it in 8 quarters.
  • Cabot-Wellington's Oracle position peaked at $11.5M in Q4 2013.
  • 1,537 funds tracked by Wall St. Rank held Oracle as of Q2 2015.

Based on Cabot-Wellington's 13F filing for Q2 2015, filed 11 Aug 2015.